Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone-sulbactam for hematology patients with bacterial infection
CTR20150336Phase 4Active
- Sponsor
- Xiangbei Welman Pharmaceuticals
- Start
- May 2015
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ceftriaxone + sulbactam in bacterial disease, sponsored by Xiangbei Welman Pharmaceuticals. Started May 2015; status: active.
02
Drugs
ceftriaxone + sulbactam
03
Conditions
bacterial disease
Beyond the preview
Go deeper on CTR20150336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150336.